1 Brignole M, Vardas P, Hoffman E, Huikuri H, Moya A, Ricci R, et al.; Task Force members; EHRA Scientific Documents Committee; Document Reviewers; EHRA Scientific Documents Committee. Indications for the use of diagnostic implantable and external ECG loop recorders. Europace. 2009;11(5):671–87. doi:https://doi.org/10.1093/europace/eup097.
2 Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347(12):878–85. doi:https://doi.org/10.1056/NEJMoa012407.
3 Edvardsson N, Frykman V, van Mechelen R, Mitro P, Mohii-Oskarsson A, Pasquié JL, et al.; PICTURE Study Investigators. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace. 2011;13(2):262–9. doi:https://doi.org/10.1093/europace/euq418.
4 Waktare JE, Malik M. Holter, loop recorder, and event counter capabilities of implanted devices. Pacing Clin Electrophysiol. 1997;20(10 Pt 2):2658–69. doi:https://doi.org/10.1111/j.1540-8159.1997.tb06114.x.
5 Krahn AD, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation. 2001;104(1):46–51. doi:https://doi.org/10.1161/01.CIR.104.1.46.
6 Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32(12):2735–40. doi:https://doi.org/10.1161/hs1201.100209.
7 Bhatt A, Majid A, Razak A, Kassab M, Hussain S, Safdar A. Predictors of occult paroxysmal atrial fibrillation in cryptogenic strokes detected by long-term noninvasive cardiac monitoring. Stroke Res Treat. 2011;2011:172074. doi:https://doi.org/10.4061/2011/172074.
8 Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al.; CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478–86. doi:https://doi.org/10.1056/NEJMoa1313600.
9 Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18(11):1609–78. doi:https://doi.org/10.1093/europace/euw295.
10 Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gérard F, et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation. 2006;114(22):2317–24. doi:https://doi.org/10.1161/CIRCULATIONAHA.106.628537.